Lilly CSO Dan Skovronsky (L) and Andrew Adams, co-director of the Lilly Institute for Genetic Medicine

Q&A: Lil­ly’s top sci­en­tists on ge­net­ic med­i­cine am­bi­tions, and how they’re not just for rare dis­eases

Last week, Eli Lil­ly opened the doors of its new re­search cen­ter in Boston, large­ly fo­cused on ge­net­ic ther­a­pies. While the In­di­anapo­lis …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.